Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Atherosclerosis ; 174(1): 111-20, 2004 May.
Artículo en Inglés | MEDLINE | ID: mdl-15135259

RESUMEN

Critical lower limb ischemia is a common cause for amputation. To develop new therapeutic strategies, more information is needed about molecular mechanisms of tissue responses to ischemic stress and factors inducing angiogenesis. Using a DNA array of 8400 genes, gene expression patterns in human skeletal muscle samples collected from lower limbs amputated due to acute-on-chronic or chronic critical lower limb ischemia, were compared with the control samples collected from the same limb. The results were confirmed by RT-PCR and immunohistochemistry. In acute-on-chronic ischemia, 291 genes were significantly upregulated and 174 genes were downregulated (change in 5.5% of all genes) as compared to control samples. Significant induction of the hypoxia-inducible angiogenic pathway involving hypoxia-inducible factor-1alpha (HIF-1alpha), HIF-2alpha, vascular endothelial growth factor (VEGF) and its angiogenic receptor VEGFR-2, as well as tumor necrosis factor-alpha (TNF-alpha) with its downstream signaling machinery promoting inflammation and cell death, were found in acute-on-chronic ischemia. In chronic critical ischemia, gene expression changes were much less striking than in acute-on-chronic ischemia, with 74 genes significantly upregulated and 34 genes downregulated (change in 1.3% of all genes). In the chronic situation, the anabolic and survival factors, insulin-like growth factor-1 (IGF-1) and IGF-2, were upregulated in atrophic and regenerating myocytes together with attenuated HIF, VEGF, and VEGFR-2 expression in the same cells. In conclusion, acute-on-chronic and chronic human skeletal muscle ischemia result in distinct gene expression patterns. These findings may be of importance in the design of novel therapies, such as therapeutic vascular growth, for patients suffering from lower limb ischemia.


Asunto(s)
Isquemia/genética , Músculo Esquelético/irrigación sanguínea , Somatomedinas/metabolismo , Factores de Transcripción/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Receptor 2 de Factores de Crecimiento Endotelial Vascular/metabolismo , Enfermedad Aguda , Biopsia con Aguja , Estudios de Casos y Controles , Enfermedad Crónica , Enfermedad Crítica , Técnicas de Cultivo , Femenino , Regulación de la Expresión Génica , Marcadores Genéticos , Humanos , Subunidad alfa del Factor 1 Inducible por Hipoxia , Inmunohistoquímica , Isquemia/patología , Extremidad Inferior , Masculino , Neovascularización Patológica/genética , Neovascularización Patológica/fisiopatología , Enfermedades Vasculares Periféricas/diagnóstico , Enfermedades Vasculares Periféricas/genética , Probabilidad , Pronóstico , Valores de Referencia , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Sensibilidad y Especificidad , Somatomedinas/genética , Factores de Transcripción/genética , Factor de Necrosis Tumoral alfa/genética , Regulación hacia Arriba , Factor A de Crecimiento Endotelial Vascular/genética , Receptor 2 de Factores de Crecimiento Endotelial Vascular/genética
2.
Arterioscler Thromb Vasc Biol ; 23(12): 2235-40, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14576072

RESUMEN

OBJECTIVE: Inflammatory cells play an important role in atherogenesis. However, more information is needed about their gene expression profiles in human lesions. METHODS AND RESULTS: We used laser microdissection (LMD) to isolate macrophage-rich shoulder areas from human lesions. Gene expression profiles in isolated cells were analyzed by cDNA array and compared with expression patterns in normal intima and THP-1 macrophages. Upregulation of 72 genes was detected with LMD and included 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, interferon regulatory factor-5 (IRF-5), colony stimulating factor (CSF) receptors, CD11a/CD18 integrins, interleukin receptors, CD43, calmodulin, nitric oxide synthase (NOS), and extracellular superoxide dismutase (SOD). Several of these changes were also present in PMA-stimulated THP-1 macrophages in vitro. On the other hand, expression of several genes, such as VEGF, tissue factor pathway inhibitor 2, and apolipoproteins C-I and C-II, decreased. CONCLUSIONS: Overexpression of HMG-CoA reductase in macrophage-rich lesion areas may explain some beneficial effects of statins, which can also modulate increased expression of CD11a/CD18 and CD43 found in microdissected cells. We also found increased expression of CSF receptors, IRF-5, and interleukin receptors, which could become useful therapeutic targets for the treatment of atherosclerotic diseases.


Asunto(s)
Arteriosclerosis/genética , Movimiento Celular , Hidroximetilglutaril-CoA Reductasas/biosíntesis , Integrinas/biosíntesis , Rayos Láser , Macrófagos/metabolismo , Macrófagos/patología , Receptores de Superficie Celular/biosíntesis , Arteriosclerosis/metabolismo , Arteriosclerosis/patología , Antígeno CD11a/biosíntesis , Antígenos CD18/biosíntesis , Células Cultivadas , Perfilación de la Expresión Génica , Regulación Enzimológica de la Expresión Génica/genética , Humanos , Inflamación/genética , Inflamación/patología , Macrófagos/química , Monocitos/química , Monocitos/metabolismo , Análisis de Secuencia por Matrices de Oligonucleótidos , Receptores del Factor Estimulante de Colonias/biosíntesis , Receptores de Interleucina/biosíntesis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA